Canopy Growth (CGC) Reports Q2 Loss of C$1.52/Share, Revenues Rise 33%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Canopy Growth Corporation Reports Second Quarter Fiscal 2019 Financial Results
November 14, 2018 6:30 AM ESTThe Company secured a strategic $5 billion investment from Fortune 500 beverage leader Constellation Brands Since October 1, Company SKUs obtained over 30% listings market share1 in multi-store physical retail store networks nationwide, strategic phase 2 rollout of value added products including edible Softgels and pre-rolled joints expected to increase market share Acquisition of Canopy Health Innovations and announced plan to acquire ebbu Inc. reinforces the Company's commitment to owned IP; Company completed or acquired over 120 patent filings across hardware, product formulation, genetics, production innovation, and medical treatments Company... More
